Recombinant Bacillus subtilis Methionine aminopeptidase 2 (mapB)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the available format, but please note any format requirements when ordering, and we will accommodate your request if possible.
Lead Time
Delivery times vary by purchase method and location. Please contact your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance as extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form typically lasts 6 months at -20°C/-80°C. Lyophilized form typically lasts 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during production. If you require a specific tag, please let us know and we will prioritize developing it.
Synonyms
mapB; yflG; BSU07690Methionine aminopeptidase 2; MAP 2; MetAP 2; EC 3.4.11.18
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-249
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacillus subtilis (strain 168)
Target Names
mapB
Target Protein Sequence
MIVTNDQELE GLKKIGRIVA LAREEMKRKA EPGMSTKDLD LIGKAVLDEH GAVSAPEKEY DFPGVTCISV NDEVAHGIPS TSKILKAGDL VNIDISAEFG GFYSDTGISF VLGEGEERLH KLCQCAENAF QKGLQQAKAG KRQNQIGRAV YHEARSQGFT VIKTLTGHGI GRSLHEAPNH IMNYYDPFDN ALFKNGTVIA LEPFISTKAE TIVEAGDGWT FKTPDKSMVA QVEHTIVITK DEPIILTKL
Uniprot No.

Target Background

Function
Removes the N-terminal methionine from newly synthesized proteins. Cleavage often occurs when the second amino acid is small and uncharged (Ala, Cys, Gly, Pro, Ser, Thr, or Val, following Met). Requires deformylation of the N-terminal methionine before hydrolysis.
Database Links
Protein Families
Peptidase M24A family, Methionine aminopeptidase type 1 subfamily
Subcellular Location
Cytoplasm.

Q&A

What methionine aminopeptidase genes are present in Bacillus subtilis?

Two putative methionine aminopeptidase genes exist in B. subtilis: map (often referred to as mapA, found to be essential) and yflG (sometimes called mapB, non-essential under laboratory conditions) . Biochemical assays have confirmed that both proteins exhibit methionine aminopeptidase activity in vitro, catalyzing the removal of N-terminal methionine from newly synthesized proteins .

How do the sequence characteristics of these enzymes compare?

The sequence similarity between E. coli MAP (MAP_Ec) and B. subtilis MAP (MAP_Bs) is 65% with 46% identity. Similarity between MAP_Ec and YflG from B. subtilis (YflG_Bs) is 55% with 34% identity. Between MAP_Bs and YflG_Bs, there is 58% similarity with 36% identity . YflG_Bs differs slightly from the PROSITE consensus for type I MAPs (PS00680) .

How can I demonstrate the functional activity of recombinant mapB in vivo?

A complementation approach using MAP-deficient strains provides strong evidence of functional activity. For example, E. coli mutant EM9 (containing an engineered map gene under IPTG control) can be used as a test system. By introducing B. subtilis mapB into this strain using vectors with inducible promoters (such as arabinose-inducible pBAD), you can assess whether mapB rescues growth in the absence of IPTG . Growth under varying arabinose concentrations can further quantify the effectiveness of complementation.

What expression systems are most effective for producing recombinant mapB protein?

E. coli expression systems have been successfully used to overproduce both MAP_Bs and YflG_Bs as pure proteins with demonstrated methionine aminopeptidase activity . Vectors with arabinose-inducible promoters, such as pBAD, provide controlled expression and have successfully produced functional enzyme for biochemical characterization .

How can I determine if mapB is essential in my bacterial strain of interest?

To resolve conflicting evidence regarding essentiality, employ targeted genetic deletion approaches:

  • Attempt direct gene knockout of mapB

  • Create a conditional mapB mutant using inducible expression systems

  • Perform plasmid-based complementation experiments where a second copy of mapB is maintained while attempting deletion of the chromosomal copy

  • Use antibiotic resistance markers to track the presence of complementing plasmids

If the gene is essential, deletion mutants will not be viable unless a functional copy is provided elsewhere in the genome .

How do methionine aminopeptidases relate to other protein processing pathways?

Methionine aminopeptidases work cooperatively with deformylases in bacterial protein maturation. Interestingly, evolutionary analysis reveals a coordinated pattern of MAP and deformylase evolution that does not correlate with the pattern of 16S RNA evolution . This suggests co-evolution of these enzymes that participate in sequential steps of N-terminal protein processing.

What factors might explain the essentiality differences between mapA and mapB in different bacterial species?

The essentiality pattern varies across bacterial species. In B. subtilis, map (mapA) is essential while yflG (mapB) is dispensable , whereas in mycobacteria, mapB is indispensable while mapA is not . This differential essentiality may be explained by:

  • Variation in expression levels (map promoter activity in B. subtilis is 50-100 fold higher than yflG)

  • Differences in enzymatic efficiency (YflG_Bs is ~100× more efficient on synthetic substrates)

  • Species-specific substrate preferences

  • Partial redundancy between the enzymes (double-deletion experiments show partial but not full redundancy)

How does genetic transformation affect mapB studies in B. subtilis?

B. subtilis naturally develops competence and can undergo spontaneous transformation . This characteristic can be leveraged for genetic mapping and manipulation of mapB. Research shows that genetic information acquired during the competence phase is inherited by the next generation after germination , making it possible to introduce mutations or modified versions of mapB through transformation with linear DNA fragments.

What approaches can be used to study the global effects of mapB activity on the proteome?

Comprehensive proteome mapping approaches can be applied to study mapB's impact. From the approximately 4,100 B. subtilis genes, around 2,515 are actively transcribed in cells grown under standard conditions . Proteome analysis using standard gel systems (pI 4-7) and supplementary zoom gels can detect around 693 expressed proteins . These techniques can be used to compare wild-type and mapB-depleted or modified strains to identify proteins whose processing is affected by mapB activity.

How can genomic manipulation techniques be applied to study mapB function?

Experimental "surgery" techniques allow for the manipulation of specific genomic segments in B. subtilis. For example, a 310-kb genomic DNA segment can be excised and replicated as an independent replicon . This approach could be used to isolate mapB in a controlled genomic context to study its regulation, expression, and function without interference from other genomic elements.

How can point mutations in mapB be used to study enzyme function?

Introduction of point mutations in mapB can create proteins with partial activity. This approach has been used to show partial redundancy between mapB and mapA . By designing specific mutations in catalytic residues or substrate binding regions, researchers can dissect the structure-function relationships of mapB and determine which residues are critical for its essential activities.

What factors might affect the activity of recombinant mapB in biochemical assays?

Several factors can influence recombinant mapB activity:

FactorConsideration
Metal cofactorsMethionine aminopeptidases require metal ions for activity; test both cobalt and zinc
Protein foldingEnsure proper folding during expression and purification
Buffer conditionsOptimize pH, salt concentration, and reducing agents
Substrate selectionUse appropriate peptide substrates that mimic natural targets
Enzyme concentrationTitrate enzyme concentration to ensure linear reaction rates

How can I verify that my recombinant mapB is properly folded and active?

Multiple approaches can verify proper folding and activity:

  • Enzymatic assays using synthetic peptide substrates

  • Complementation of map-deficient strains

  • Circular dichroism to assess secondary structure

  • Limited proteolysis to evaluate structural integrity

  • Size exclusion chromatography to confirm appropriate oligomeric state

What might cause inconsistent results in mapB genetic manipulation experiments?

Spontaneous transformation can occur in B. subtilis between competent cells and DNA released from lysed cells . This natural genetic exchange could introduce unintended genetic changes during mapB manipulation experiments. Control for this by:

  • Using transformation-deficient strains for certain experiments

  • Carefully selecting growth media that minimize competence development

  • Verifying genetic stability through regular sequencing

  • Including appropriate controls to detect spontaneous transformation events

How does B. subtilis mapB compare to methionine aminopeptidases in other bacterial species?

The table below summarizes key comparative features:

SpeciesEssential MAPNon-essential MAPNotes
B. subtilismap (mapA)yflG (mapB)mapB has higher enzymatic efficiency despite lower expression
MycobacteriamapBmapAConflicting reports resolved through genetic deletion studies
E. coliSingle map geneNone identifiedCan be complemented by either B. subtilis map or yflG

What evolutionary patterns are observed in methionine aminopeptidase systems?

Phylogenetic analysis reveals that MAP evolution follows an erratic evolutionary pattern similar to deformylases, rather than matching 16S rRNA evolutionary distances . This suggests co-evolution between these functionally related enzymes involved in N-terminal protein processing, potentially driven by selective pressures on protein maturation pathways.

How can understanding B. subtilis mapB inform studies of methionine aminopeptidases in pathogenic bacteria?

Insights from B. subtilis mapB can inform therapeutic targeting of methionine aminopeptidases in pathogenic bacteria. The resolution of conflicting essentiality data in mycobacteria highlights the importance of careful genetic validation when identifying potential drug targets. The functional redundancy observed between mapA and mapB suggests that effective therapeutic strategies might need to target both enzymes or specifically target the essential variant.

What emerging technologies might enhance our understanding of mapB function?

Recent developments in genomic manipulation, such as CRISPR-Cas systems adapted for B. subtilis, offer new possibilities for precise genetic manipulation of mapB. Additionally, advances in proteomics technologies, particularly those focused on N-terminal peptide analysis, can provide comprehensive insights into the in vivo substrates and specificity of mapB.

How might mapB research contribute to understanding bacterial adaptation and evolution?

The co-evolutionary pattern observed between methionine aminopeptidases and deformylases suggests these systems may adapt together to environmental pressures. Further research on mapB across diverse bacterial species and environmental conditions could reveal how N-terminal protein processing contributes to bacterial adaptation and evolution.

What are the implications of mapB research for antimicrobial development?

The essential nature of methionine aminopeptidases in bacteria makes them potential targets for antimicrobial development. The differences in essentiality patterns and enzymatic properties between bacterial species suggest that species-specific approaches may be required for effective targeting. Understanding the structural and functional details of mapB can inform the design of selective inhibitors that target bacterial methionine aminopeptidases without affecting human counterparts.

What are the recommended protocols for recombinant mapB expression and purification?

StepProcedureCritical Parameters
CloningInsert mapB (yflG) gene into expression vectorConfirm sequence integrity
ExpressionTransform into E. coli, induce with appropriate inducerOptimize temperature, inducer concentration, and duration
Cell lysisSonication or mechanical disruptionInclude protease inhibitors
PurificationAffinity chromatography followed by size exclusionEnsure metal cofactor inclusion
Activity verificationEnzymatic assay with synthetic substratesCompare with established benchmarks

What are the standard assay conditions for measuring mapB activity?

ParameterRecommended ConditionNotes
Buffer50 mM HEPES or Tris-HCl, pH 7.5Optimize pH based on specific substrates
Temperature30°CTypical for B. subtilis enzymes
Metal cofactor1 mM Co²⁺ or Zn²⁺Co²⁺ often provides higher activity
SubstrateMet-X peptidesX can vary to test specificity
Detection methodHPLC, fluorescence, or colorimetric assaysChoose based on available equipment

How can I standardize genetic manipulation experiments with mapB?

For consistent genetic manipulation:

  • Use defined competence and sporulation medium (CSM) for transformation experiments

  • Verify integration and orientation of genetic constructs by Southern hybridization

  • Use complementation systems with selectable markers to maintain essential genes

  • Design genetic constructs with appropriate homology regions for efficient recombination

  • Include appropriate controls to detect spontaneous transformation events

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.